Comprehensive Analysis of Endoplasmic Reticulum-related and Secretome Gene Expression Profiles in the Progression of Non-alcoholic Fatty Liver Disease
Overview
Authors
Affiliations
Endoplasmic reticulum (ER) is the principal organelle for protein synthesis, such as hepatokines and transmembrane proteins, and is critical for maintaining physiological function. Dysfunction of ER is associated with metabolic disorders. However, the role of ER homeostasis as well as hepatokines in the progression of non-alcoholic fatty liver disease (NAFLD) remains to be elucidated. Here we comprehensively analyzed the RNA-seq profiles of liver biopsies from 206 NAFLD patients and 10 controls from dataset GSE135251. The co-expression modules were constructed based on weighted gene co-expression network analysis and six co-expression modules were identified, of which brown module stood out to be significantly associated with fibrosis stage and NAFLD activity score (NAS). Subsequently, cytoscape with cytoHubba plugin was applied to identify hub genes in the brown module. GO and KEGG enrichment analysis of the top 20 hub genes were performed and showed the involvement of extracellular matrix formation, collagen synthesis and decomposition, etc. Further, the expression of the top 20 hub genes were found to be a consistent increasing trend as the fibrosis stages and NAS increased, which have been validated both in HFD fed and HFHC fed mice. Among these genes, , , , , , , , , and performed well in distinguishing fibrosis stage, while , , , and exhibited good capacity to discriminate NAS. Besides, , , , , , , , , and also showed a strong power in the diagnosis of NAFLD. In addition, , , , , , , , , and were identified as secretome genes from the top 20 hub genes. Of them, circulated and collagen III level were validated to be significantly elevated in the MCD diet-induced mice. Thus, we provided a systemic view on understanding the pathological roles and mechanisms of ER as well as secretome in NAFLD progression. , , , and could be served as candidate biomarkers to evaluate the progression of NAFLD.
Lai P, Miao G, Zhao Y, Han Y, Li Y, Liu Y Nat Commun. 2025; 16(1):2430.
PMID: 40069146 PMC: 11897346. DOI: 10.1038/s41467-025-57585-0.
Pemigatinib suppresses liver fibrosis and subsequent osteodystrophy in mice.
Mihara T, Tsuru Y, Kurosawa T, Nonoshita Y, Yamakawa Y, Hori M Hepatol Commun. 2025; 9(1.
PMID: 39774090 PMC: 11717528. DOI: 10.1097/HC9.0000000000000610.
Multiple Machine Learning Identifies Key Gene PHLDA1 Suppressing NAFLD Progression.
Yang Z, Chen Z, Wang J, Li Y, Zhang H, Xiang Y Inflammation. 2024; .
PMID: 39496918 DOI: 10.1007/s10753-024-02164-6.
Li J, Yang L, Xiao M, Li N, Huang X, Ye L Liver Int. 2024; 45(4):e16125.
PMID: 39400982 PMC: 11891380. DOI: 10.1111/liv.16125.
Liu Y, Li J, Tian S, Lan Q, Sun Z, Liu C Front Immunol. 2024; 15:1357632.
PMID: 38550602 PMC: 10972886. DOI: 10.3389/fimmu.2024.1357632.